Fulgent Genetics (FLGT) EBIAT (2016 - 2025)
Historic EBIAT for Fulgent Genetics (FLGT) over the last 11 years, with Q3 2025 value amounting to -$6.8 million.
- Fulgent Genetics' EBIAT rose 5354.57% to -$6.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$44.2 million, marking a year-over-year increase of 7431.38%. This contributed to the annual value of -$43.8 million for FY2024, which is 7499.42% up from last year.
- Per Fulgent Genetics' latest filing, its EBIAT stood at -$6.8 million for Q3 2025, which was up 5354.57% from -$19.3 million recorded in Q2 2025.
- Fulgent Genetics' EBIAT's 5-year high stood at $200.7 million during Q1 2021, with a 5-year trough of -$134.3 million in Q4 2023.
- Moreover, its 5-year median value for EBIAT was -$9.1 million (2024), whereas its average is $20.7 million.
- As far as peak fluctuations go, Fulgent Genetics' EBIAT surged by 1036027.61% in 2021, and later plummeted by 88336.24% in 2023.
- Over the past 5 years, Fulgent Genetics' EBIAT (Quarter) stood at $104.3 million in 2021, then crashed by 123.07% to -$24.1 million in 2022, then crashed by 457.96% to -$134.3 million in 2023, then soared by 95.39% to -$6.2 million in 2024, then dropped by 10.27% to -$6.8 million in 2025.
- Its EBIAT stands at -$6.8 million for Q3 2025, versus -$19.3 million for Q2 2025 and -$11.9 million for Q1 2025.